Natco Pharma informs about press release

03 Nov 2017 Evaluate

Natco Pharma has informed about press release titled ‘Natco’s marketing partner Alvogen first to market generic equivalent to oseltamivir phosphate powder for oral suspension in the USA’.

The above information is a part of company’s filings submitted to BSE.

Natco Pharma Share Price

888.50 -15.05 (-1.67%)
01-Jan-2026 14:19 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1721.05
Dr. Reddys Lab 1250.75
Cipla 1500.90
Zydus Lifesciences 913.95
Lupin 2105.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×